Dr. Shaobo Zhu

Dr.Shaobo ZhuShaobo Zhu, MD
Anatomic Pathology, Clinical Pathology, Cytopathology
Section Head, Thoracic Pathology

100 North Academy Avenue
Danville, PA  17822-1920
800-695-6491

Dr. Zhu is an associate of Geisinger Medical Laboratories at Danville, Pennsylvania. He is also on the faculty of the Geisinger Cytopathology Fellowhsip Program.

Education:

Dr. Zhu received his MD from Sun Yat-Sen University of Medical Sciences in Guangzhou, China. He completed an internship in the Department of Surgery at University of Michigan Hospital, Ann Arbor. He received residency training in combined anatomic and clinical pathology at Temple University Hospital in Philadelphia, Pennsylvania, and fellowship training in cytopathology at Geisinger Medical Center.

Certifications:

Dr. Zhu is board certified in both anatomic and clinical pathology and cytopathology.

Professional Affiliations:

American Association of Cytopathology
United States and Canadian Academy of Pathology

Research Interests:

Cytopathology; pediatric pathology; cervical gynecologic, genitourinary, thoracic, head and neck (ENT) pathology, soft tissue, thyroid and gastrointestinal pathology.

Recent Academic Activity

Publications in Peer-Reviewed Journals:

Zhu S, Schuerch C, Hunt J.. Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors. Arch Pathol Lab Med 2015;139(1):55-66.

Lin F, Shi J, Zhu S, Chen Z, Li A, Chen T, Wang HL, Liu H. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med 2014;138:1015-1026.

Abstracts, Posters, and Other Presentations:

Rizwan R, Bowen TR, Zhu S, Gardner JM.. High-grade Osteosarcoma with Background Low-grade Osteosarcoma in a Pregnant Female with Rothmund-Thomson Syndrome. Presentation College of American Pathologists (CAP) annual meeting , New Orleans, LA, October 2022.

Rizwan R. Chen G, Zhu S, Gardner J. Primary Esophageal Spindle Cell Melanoma with Striking Ribbon-Like Nuclear Palisading: A Diagnostic Challenge. Virtual Presentation American Society of Dermatopathology , Virtual, October 20-24, 2021.

Zhang CQ, Yin H, Zhu S, Chen ZE. . Use ALK immunohistochemistry (IHC) assay to screen for ALK plus lung adenocarcinoma: equivocal staining pattern is a practical challenge. Abstract United States and Canadian Academy of Pathology Annual Meeting, Vancouver, British Columbia, March 17-23, 2018.

Yin H, Zhang CQ, Zhu S, Zelonis M, Snyder D, Schiccatano K, Quinones W, Chen ZE. Identifying ALK+ Lung Adenocarcinoma: Practical Insights Learnt from Concurrent Fluorescence in situ Hybridization (FISH) and Immunohistochemistry (IHC) Test of 126 Clinical Specimens . Abstract United States and Canadian Academy of Pathology Annual Meeting, Vancouver, British Columbia, March 17-23, 2018.

Yin H, Zhu S, Zelonis M, Snyder D, Kip NS, Chen ZE. Patchy high frequency of nonspecific abnormal signals (background noise): a common pitfall in interpretation of ALK FISH results. Abstract USCAP Annual Meeting, Boston, March 12-18, 2016.

Chen Z, Yin H, Li J, Zhu S, Lin F. Improving HER2 assessment in gastroesophageal junction (GEJ) and gastric adenocarcinoma (GADC): lessons from concurrent immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) study of 117 specimens. Abstract/Presentation USCAP Annual Meeting, Boston, MA, March 2015.

Yin H, Zhu S, Zelonis M,. Insufficient formalin fixation can negatively affect detection of ALK rearrangement in lung cancer by fluorescence in situ hybridization (FISH). Poster USCAP Annual Meeting, Boston, MA, March 21-27, 2015.

Yin H, Zhu S, Zelonis M, Snyder D, Kip NS, Chen ZM. Insufficient formalin fixation can negatively affect detection of ALK rearrangement in lung cancer by fluorescence in situ hybridization (FISH). Presentation United States &Canadian Academy of Pathology, Boston, Massachusetts, March 17-21, 2015.

Zhu S, Lin F, Chen ZM, . Low frequency of HER2 overexpression and amplification detected by immunohistochemical stain and dual chromogenic in situ hybridization (CISH) in pancreatic ductal adenocarcinoma. Presentation CAP Annual Meeting, Orlando, FL, October 13-16, 2013.

Chen ZM, Zhu S, Liu H, Lin F. Loss expression of CDX2 and CK20 in medullary carcinoma of the colon is associated with poor survival. Presentation CAP Annual Meeting, Orlando, FL, October 13-16, 2013.

Johnson B, Khalil M, Blansfield J, Lin F, Zhu S, Kirchner HL. Investigating the prognostic value of a panel of biomarkers after curative intent resection of pancreatic ductal adenocarcinoma. Presentation ASCO Annual Meeting, San Francisco, CA, May 2013.

Zhu S, Lin F, Chen ZM. Mitosis-specific marker PHH3 immunostain is a more sensitive and efficient method to evaluate the mitotic activity in gastrointestinal stromal tumor (GIST). Presentation USCAP Annual Meeting , Baltimore, MD, March 2-8, 2013.

Textbook Chapters

Zhu S, Miettinen M, Lin G. Soft Tissue and Bone Tumors. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer, New York, 2015, pp. 557-590.

Schuerch C, Zhu S. Salivary Glands and Head and Neck. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. Springer, New York, 2015, pp. 287-312.

Locations  |    Search  |    Site Map |   Contact Us

©2000-2024 Geisinger Health System.   All rights reserved.